Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fulzerasib tablets

Approval Number

国药准字H20240035

Company信达生物科技有限公司

Registration Date

August 20, 2024

Drug Information

Generic Name

氟泽雷塞片

Trade Name

达伯特

Dosage Form

片剂

Strength

0.15g

Drug Type

化学药品

Registration Date

August 20, 2024

Company Information

Applicant Company

Company Name信达生物科技有限公司

Company Address

上海市闵行区金光路999号2幢全天候研发中心、6幢地下室

Manufacturing Company

Company Name康龙化成（宁波）科技发展有限公司

Company Address

浙江省宁波杭州湾新区滨海四路800号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy